This protocol is judged by an institutional overview board, an impartial group that critiques any clinical trials involving human beings. If a study will involve a Routine I drug, after the board approves the protocol as ethical, the researchers need to apply for an investigational new drug (IND) amount within the FDA.This article includes a listi